Original Research
Accepted on 15 Jun 2025
Dexmedetomidine Reduces In-Hospital Mortality in Aneurysmal Subarachnoid Hemorrhage Patients by Modulating Three Key Genes and Inflammatory Pathways: Insights from Clinical and Bioinformatics Analyses
in Endovascular and Interventional Neurology